Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT

References

• Price A. Emerging developments of chemoradiotherapy in stage III NSCLC. Nat Rev Clin Oncol. 2012;9:591–598.
   PubMed Web of Science ®Google Scholar
• Aupérin A, Le Péchoux C, Rolland E, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010;28:2181–2190.
   PubMed Web of Science ®Google Scholar
• Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol. 1999;17:2692–2699.
   PubMed Web of Science ®Google Scholar
• Velazquez ER, Aerts HJ, Oberije C, et al. Prediction of residual metabolic activity after treatment in NSCLC patients. Acta Oncol. 2010;49:1033–1039.
   PubMed Web of Science ®Google Scholar
• Machtay M, Paulus R, Moughan J, et al. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. J Thorac Oncol. 2012;7:716–722.
   PubMed Web of Science ®Google Scholar
• McGarry RC. Integrating stereotactic body radiation therapy in stage II/III non-small cell lung cancer: is local control important? Expert Rev Anticancer Ther. 2014;14:1419–1427.
   PubMed Web of Science ®Google Scholar
• Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324–333.
   PubMed Web of Science ®Google Scholar
• Belderbos JS, Heemsbergen WD, De Jaeger K, et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:126–134.
   PubMed Web of Science ®Google Scholar
• Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16:187–199.
   PubMed Web of Science ®Google Scholar
• Mac Manus MP, Everitt S, Bayne M, et al. The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data. Radiother Oncol. 2013;106:292–298.
   PubMed Web of Science ®Google Scholar
• Aerts HJ, van Baardwijk AA, Petit SF, et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. Radiother Oncol. 2009;91:386–392.
   PubMed Web of Science ®Google Scholar
• Aerts HJ, Bussink J, Oyen WJ, et al. Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. Lung Cancer. 2012;75:73–76.
   PubMed Web of Science ®Google Scholar
• Calais J, Thureau S, Dubray B, et al. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer. J Nucl Med. 2015;56:196–203.
   PubMed Web of Science ®Google Scholar
• Møller DS, Holt MI, Alber M, et al. Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose. Radiother Oncol. 2016;121:32–38.
   PubMed Web of Science ®Google Scholar
• El-Sherief AH, Lau CT, Wu CC, et al. International association for the study of lung cancer (IASLC) lymph node map: radiologic review with CT illustration. Radiographics. 2014;34:1680–1691.
   PubMed Web of Science ®Google Scholar
• Aerts HJ, Bosmans G, van Baardwijk AA, et al. Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study. Int J Radiat Oncol Biol Phys. 2008;71:1402–1407.
   PubMed Web of Science ®Google Scholar
• Petit SF, Aerts HJ, van Loon JG, et al. Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study. Radiother Oncol. 2009;91:393–398.
   PubMed Web of Science ®Google Scholar
• Moeller DS, Khalil AA, Knap MM, et al. A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients. Acta Oncol. 2011;50:883–888.
   PubMed Web of Science ®Google Scholar
• Nielsen TB, Hansen O, Schytte T, et al. Four-dimensional dose evaluation of inhomogeneous dose distributions planned for non-small cell lung cancer patients with lymph node involvement. Acta Oncol. 2014;53:707–712.
   PubMed Web of Science ®Google Scholar
• Feng M, Kong FM, Gross M, et al. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys. 2009;73:1228–1234.
   PubMed Web of Science ®Google Scholar
• van Elmpt W, De Ruysscher D, van der Salm A, et al. The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer. Radiother Oncol. 2012;104:67–71.
   PubMed Web of Science ®Google Scholar
• Domachevsky L, Jacene HA, Sakellis CG, et al. Postradiation changes in tissues: evaluation by imaging studies with emphasis on fluorodeoxyglucose-PET/computed tomography and correlation with histopathologic findings. PET Clin. 2014;9:217–235.
   PubMedGoogle Scholar
• Moreno-Jiménez M, Aristu J, López-Picazo JM, et al. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation. Radiother Oncol. 2008;88:342–350.
   PubMed Web of Science ®Google Scholar
• Schytte T, Nielsen TB, Brink C, et al. Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer. Acta Oncol. 2014;53:336–341.
   PubMed Web of Science ®Google Scholar
• Billiet C, De Ruysscher D, Peeters S, et al. Patterns of locoregional relapses in patients with contemporarily staged stage III-N2 NSCLC treated with induction chemotherapy and resection: implications for postoperative radiotherapy target volumes. J Thorac Oncol. 2016;11:1538–1549.
   PubMed Web of Science ®Google Scholar
• Topol M, Masłoń A. Some variations in lymphatic drainage of selected bronchopulmonary segments in human lungs. Ann Anat. 2009;191:568–574.
   PubMed Web of Science ®Google Scholar